Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 laser-assisted photodynamic therapy vs keratolytic treatment for therapy-resistant plantar warts
2010-020933-25Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jul 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in plantar wart comparing Fractional CO2 laser-assisted Metvix photodynamic therapy with Keratolytic treatment with Verucid gel (2 arms). Primary endpoint: Number of plantar warts at end of study compared to baseline. Started Jul 2010; status: completed.
02
Drugs
methyl aminolevulinatesalicylic acid + lactic acid + copper acetate
03
Conditions
plantar wart
Beyond the preview
Go deeper on 2010-020933-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020933-25.